Midgard Science

Biomay AG

Vienna, Austria biomay.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Biomay AG is a biopharmaceutical CDMO in Vienna, Austria. It manufactures GMP-grade plasmid DNA, mRNA, recombinant proteins, and related drug products for clinical phases I–III and market supply. The company operates two GMP manufacturing sites in Vienna.

Services

  • Vector development

    Develops vectors for plasmids, proteins, and mRNA.

    Cell line development

  • GMP cell banking

    Creates Master Cell Banks and Working Cell Banks.

    Cell line development

  • Process development and feasibility studies

    Carries out process development and feasibility work for client projects.

  • Analytical development / quality control methods

    Develops analytical methods and quality control methods for project support.

  • GMP manufacturing of bulk drug substance

    Manufactures bulk drug substance for clinical phases I–III and market supply.

    CDMO: development & manufacturing

  • GMP aseptic filling of drug product

    Performs aseptic filling of drug product for clinical phases I–III.

    CDMO: development & manufacturing

  • Quality control and Qualified Person release

    Provides quality control and QP release services.

  • Analytical method and process validation (PPQ)

    Supports analytical method validation and process validation activities.

4 more services
  • Regulatory support
  • ICH stability testing & long-term storage
  • Aseptic filling
  • Personalized manufacturing
Turnaround
  • Within a couple of weeks
  • From incoming of starting material to released mRNA-LNP in three weeks
  • From incoming of starting material to released plasmid DNA in two weeks
  • Personalized DNA cancer vaccines in as little as two weeks
  • mRNA-based vaccines in approximately three weeks
What to send
  • In-silico sequence of individual patient mRNA provided by sponsor
  • DNA fragment synthesis as starting material (external)
  • In-silico sequence of individual patient DNA provided by sponsor

Capabilities

Assays and studies
  • mRNA
  • Fill-finish
  • LNP
  • Analytical development
  • Cell-free expression
  • Process development
7 more
  • Quality control
  • Qualified person release
  • Analytical method validation
  • Process validation
  • ICH stability testing
  • In-house rapid sterility testing
  • Assay development
Scale and capacity
  • Two GMP manufacturing sites
  • 10 segregated GMP clean room suites
  • Total floor space 6000 sqm / 60,000 sq ft
  • Headquarter facility 4000 sqm total floor space
  • mRNA Competence Center 2000 sqm total floor space
  • Bioreactor capacities: 30L, 50L, 150L, 750L
5 more
  • Personalized bioreactor capacities: 4 x 3L
  • Capacity up to 1500 2R glass vials per batch
  • Up to 1500 sterile-filled vials per batch
  • Up to 50 mg mRNA per patient
  • Up to 300 mg DNA per patient
Therapeutic areas
  • Cancer immunotherapy
  • Gene editing
  • ATMPs

Instruments and platforms

  • Automated filling / stoppering line
  • High-pressure homogenizers
  • Centrifuges
  • Process chromatography equipment

Modalities and species

Modalities
  • mRNA
  • Viral vector
  • Gene editing
  • Recombinant protein
  • Vaccine
  • Plasmid DNA
  • LNP / formulation
Species and models
E. coli

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: plasmid DNA, mRNA, recombinant proteins, aseptic filling, personalized batches

Details

Type
CDMO
Founded
1984
Address
Ada-Lovelace-Straße 2; 1220 Vienna, Austria
Sites
  • Vienna 1220 (Aspern Seestadt), Austria
  • Vienna 1090, Austria
Serves
North America

Public records

Parent company
BIOMAY AG · AT GLEIF

Similar labs